Minnesota Statutes 62J.845 – Prohibition On Withdrawal of Generic or Off-Patent Drugs for Sale
Current as of: 2023 | Check for updates
|
Other versions
Subdivision 1.Prohibition.
A manufacturer of a generic or off-patent drug is prohibited from withdrawing that drug from sale or distribution within this state for the purpose of avoiding the prohibition on excessive price increases under section 62J.842.
Subd. 2.Notice to board and attorney general.
Terms Used In Minnesota Statutes 62J.845
- state: extends to and includes the District of Columbia and the several territories. See Minnesota Statutes 645.44
Terms Used In Minnesota Statutes 62J.845
- state: extends to and includes the District of Columbia and the several territories. See Minnesota Statutes 645.44
Any manufacturer that intends to withdraw a generic or off-patent drug from sale or distribution within the state shall provide a written notice of withdrawal to the attorney general at least 90 days prior to the withdrawal.
Subd. 3.Financial penalty.
The attorney general shall assess a penalty of $500,000 on any manufacturer of a generic or off-patent drug that the attorney general determines has failed to comply with the requirements of this section.